Advertisement

Topics

iX Biopharma???s Wafermine Commences Efficacy Study

20:00 EDT 22 Aug 2017 | BioSpace

•Solid balance sheet with S$31.1 million in cash• Robust product pipeline with a new range of nutraceutical productsSingapore, 23 August 2017 Specialty pharmaceutical company, iX Biopharma Ltd (iXBiopharma or the Group), has made significant strides in the development of its pipeline ofpharmaceutical products and the introduction of its new range of n...

Original Article: iX Biopharma???s Wafermine Commences Efficacy Study

NEXT ARTICLE

More From BioPortfolio on "iX Biopharma???s Wafermine Commences Efficacy Study"

Advertisement
Quick Search
Advertisement
Advertisement